Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Source filing unavailable
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$238.22K | -$1.09K | -$725.00 | -$731.00 |
| EPS Diluted | -$0.02 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
